These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 18927459

  • 1. Extension of the thrombolytic time window with minocycline in experimental stroke.
    Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH.
    Stroke; 2008 Dec; 39(12):3372-7. PubMed ID: 18927459
    [Abstract] [Full Text] [Related]

  • 2. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
    Sumii T, Lo EH.
    Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
    [Abstract] [Full Text] [Related]

  • 3. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W, Hendren J, Qin XJ, Liu KJ.
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [Abstract] [Full Text] [Related]

  • 4. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.
    Fan X, Lo EH, Wang X.
    Stroke; 2013 Mar; 44(3):745-52. PubMed ID: 23422086
    [Abstract] [Full Text] [Related]

  • 5. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M, Asahi K, Wang X, Lo EH.
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [Abstract] [Full Text] [Related]

  • 6. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
    Won S, Lee JH, Wali B, Stein DG, Sayeed I.
    J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
    [Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke.
    Switzer JA, Hess DC, Ergul A, Waller JL, Machado LS, Portik-Dobos V, Pettigrew LC, Clark WM, Fagan SC.
    Stroke; 2011 Sep; 42(9):2633-5. PubMed ID: 21737808
    [Abstract] [Full Text] [Related]

  • 8. Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
    Zhang L, Zhang ZG, Zhang RL, Lu M, Adams J, Elliott PJ, Chopp M.
    Stroke; 2001 Dec 01; 32(12):2926-31. PubMed ID: 11739997
    [Abstract] [Full Text] [Related]

  • 9. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M, Allahtavakoli F, Hassanipour M, Khaksari M, Rezazadeh H, Allahtavakoli M, Taghavi MM.
    Brain Res Bull; 2017 Sep 01; 134():85-90. PubMed ID: 28710023
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke.
    Fujiwara N, Murata Y, Arai K, Egi Y, Lu J, Wu O, Singhal AB, Lo EH.
    BMC Neurosci; 2009 Jul 15; 10():79. PubMed ID: 19604385
    [Abstract] [Full Text] [Related]

  • 11. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
    Tsuruoka A, Atsumi C, Mizukami H, Imai T, Hagiwara Y, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2014 Jul 15; 23(10):2894-2899. PubMed ID: 25282183
    [Abstract] [Full Text] [Related]

  • 12. Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model.
    Culp WC, Brown AT, Lowery JD, Arthur MC, Roberson PK, Skinner RD.
    Mol Neurobiol; 2015 Oct 15; 52(2):979-84. PubMed ID: 26055229
    [Abstract] [Full Text] [Related]

  • 13. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats.
    Aoki T, Sumii T, Mori T, Wang X, Lo EH.
    Stroke; 2002 Nov 15; 33(11):2711-7. PubMed ID: 12411666
    [Abstract] [Full Text] [Related]

  • 14. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M, Kawasaki K, Suzuki Y, Ishizuka F, Mishiro K, Egashira Y, Ikegaki I, Tsuruma K, Shimazawa M, Yoshimura S, Iwama T, Hara H.
    Neuroscience; 2012 Sep 18; 220():302-12. PubMed ID: 22710066
    [Abstract] [Full Text] [Related]

  • 15. Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.
    Hess DC, Fagan SC.
    Pharmacotherapy; 2010 Jul 18; 30(7 Pt 2):55S-61S. PubMed ID: 20575623
    [Abstract] [Full Text] [Related]

  • 16. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
    Hassanipour M, Zarisfi M, Ehsani V, Allahtavakoli M.
    Life Sci; 2020 Sep 01; 256():117450. PubMed ID: 32087233
    [Abstract] [Full Text] [Related]

  • 17. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J, Qi Z, Liu W, Wang P, Shi W, Dong W, Ji X, Luo Y, Liu KJ.
    Stroke; 2015 May 01; 46(5):1344-1351. PubMed ID: 25804925
    [Abstract] [Full Text] [Related]

  • 18. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
    García-Culebras A, Palma-Tortosa S, Moraga A, García-Yébenes I, Durán-Laforet V, Cuartero MI, de la Parra J, Barrios-Muñoz AL, Díaz-Guzmán J, Pradillo JM, Moro MA, Lizasoain I.
    Stroke; 2017 Jun 01; 48(6):1695-1699. PubMed ID: 28428349
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
    Yang Y, Li Q, Miyashita H, Howlett W, Siddiqui M, Shuaib A.
    J Neurosurg; 2000 May 01; 92(5):841-7. PubMed ID: 10794299
    [Abstract] [Full Text] [Related]

  • 20. Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke.
    Gautier S, Ouk T, Tagzirt M, Lefebvre C, Laprais M, Pétrault O, Dupont A, Leys D, Bordet R.
    J Neuroinflammation; 2014 May 27; 11():96. PubMed ID: 24885160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.